<ul class="summary-bullets"><li>Oracle stock has declined 47% from the start of June.</li><li>Retail traders said Oracle’s execution on its contracts and the resilience of broader AI sentiment would be key.</li><li>Stocktwits sentiment for ORCL climbed to ‘extremely bullish’ and message volume rose over 2,300% as the dip attracted fresh interest from traders.</li></ul>Oracle Corp. shares&nbsp;tumbled 6.5% on Monday to their lowest level in 14 months as a fresh escalation between the U.S. and Iran rattled markets in the U.S. and around the world.Shares edged slightly higher in overnight trading, but the move sparked a wave of commentary on Stocktwits, reigniting the debate over a company that has drifted into risky territory and an increasingly negative sentiment.Oracle is in a unique position. It has one of the largest remaining performance obligations (RPO) backlogs in the tech industry but is also piling on debt at a rapid pace to build the capacity needed to fulfill those orders.Oracle’s future order book is based on business from a handful of companies, chiefly OpenAI, which itself is on&nbsp;shaky footing. Investors are erring on the side of caution in this risk-reward equation, with&nbsp;<a href="https://stocktwits.com/symbol/ORCL">ORCL shares</a> falling 47% since the start of June.<figure class="image"><img src="https://news.stocktwits-cdn.com/koyfin_20260714_083430918_png_2b54fcc388.webp" alt="koyfin_20260714_083430918.png" width="1800" height="1200"></figure>On Monday, ORCL shares fell below the crucial $134 level that had offered support to the stock this year. By evening, the ticker was trending at the top on Stocktwits, with message volume surging over 2,300% in the last 24 hours.<h2 class="st-heading-2">Retail View On ORCL</h2>“$ORCL Oracle is now trading below where it was before landing the OpenAI deal. Wall Street is repricing a $300+ billion OpenAI contract as a liability instead of an asset. In this game, retail investors are the ones absorbing the losses,” a trader&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.stocktwits.com/JDKING/message/658943804">wrote</a>.&nbsp;OpenAI and Oracle signed a $300 billion, five-year cloud computing contract last September. Beginning in 2027, Oracle will supply OpenAI with the computing power needed to train and run its frontier AI models.“The market sees the opportunity, but the concern is execution,”&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.stocktwits.com/CosmicMiner/message/658950228">said</a> a trader. “Oracle has one of the largest AI backlogs in the industry. The challenge: turning contracts into revenue while funding massive AI infrastructure. $55B+ invested in AI data centers has pressured free cash flow, with more capital needed for expansion.”The overall sentiment reading for ORCL climbed to ‘extremely bullish’ from ‘bullish’ the previous day, a shift that often follows steep declines in a stock.<h2 class="st-heading-2">Oracle’s Woes&nbsp;</h2>Last month, Oracle reported fourth-quarter results that beat expectations and said its backlog surged 363% to a record $638 billion. But it also forecasts up to $95 billion in capital expenditure for fiscal 2027, following $55.7 billion in spending last fiscal.To achieve that, Oracle said it would raise $40 billion in debt and equity this fiscal year. In the fiscal year just ended, Oracle raised $43 billion in debt financing and $5 billion in equity.While raising debt to fund expansion isn’t inherently a negative, Oracle’s reliance on OpenAI and the AI startup’s weakening position have raised concerns around the ORCL investment case.Anthropic is now valued above OpenAI and is also reported to have a higher annualized revenue run rate. With reports that OpenAI has pushed its IPO to next year, coupled with Apple’s <a href="https://stocktwits.com/news-articles/markets/equity/not-afraid-of-apple-says-open-ai-ceo-sam-altman-after-trade-secret-lawsuit/cZmzOPqR7of">lawsuit</a> alleging trade secret theft, concerns around the AI startup’s business have intensified in recent months.For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

The Oracle logo is displayed on a mobile phone with the company's branding seen in the background in this photo illustration.

ORCL Stock At 14-Month Low Amid High Debt, Execution Risks: Retail Calls $300B OpenAI Deal A 'Liability'

Oracle shares tumbled 6.5% on Monday amid a market-wide sell-off triggered by the escalation of the war in Iran.

Equity

Oracle shares tumbled 6.5% on Monday amid a market-wide sell-off triggered by the escalation of the war in Iran.


Cathie Wood Buys $21.3 Million Of SpaceX Stock As It Slides From Record Highs, Keeps Trimming AMD

Cathie Wood's Ark added to SpaceX and cut AMD again on Monday, July 13, 2026.read more...

<ul class="summary-bullets"><li>Following the announcement, oil prices rallied, with Brent crude prices soaring more than 9% during trading hours, clocking their biggest single-day gain since 2020. Oil is now trading above $80 per barrel.&nbsp;</li><li>A report from POLITICO stated that Trump had formally notified Congress that the U.S. was once more at war with Iran, in a letter dated July 10.</li><li>Meanwhile, markets will be bracing for the start of earnings season, with major banks kicking off their quarterly reports on Tuesday.&nbsp;</li></ul>U.S. stock futures traded lower overnight late Monday after tensions between the U.S. and Iran escalated further, even as President Donald Trump reinstated the naval blockade of the Middle Eastern country in the Strait of Hormuz.&nbsp;Meanwhile, markets are expecting the first wave of corporate earnings reports on Tuesday, with five of the six largest U.S. banks scheduled to&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/jpm-c-gs-bac-wfc-set-to-report-earnings-tomorrow-a-look-at-what-wall-street-s-expecting/cZmzrVRR7Yd">report</a>.&nbsp;Dow futures were down 0.18%, S&amp;P 500 futures declined 0.06%, and Nasdaq-100 futures climbed 0.13% at 9:20 PM EDT.&nbsp;&nbsp;Among ETFs tracking benchmark indexes, the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF (SPY)</a> and the&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust</a> (DIA) were trading in the red at the time of writing, while the Invesco QQQ Trust (QQQ) edged higher. The&nbsp;<a href="https://stocktwits.com/symbol/TLT">iShares 20+ Year Treasury Bond ETF (TLT)</a> was up 0.02% amid ‘bearish’ sentiment.<h2 class="st-heading-2">How Did US Markets Fare On Monday?</h2>All three benchmark indexes closed&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/s-and-p-500-nasdaq-dow-end-lower-as-us-iran-war-fear-remerges-meta-skhvy-crcl-ba-dal-in-focus/cZmC5BQR7YA">lower</a> on Monday, with the Nasdaq leading the decline, shedding over 400 points to close 1.55% lower. The S&amp;P 500 was down 0.79%, while the Dow Jones Industrial Average was 0.26% lower at the close.&nbsp;<div><figure class="table"><table class="ck-table-resized"><colgroup><col><col><col></colgroup><tbody><tr><td>Index</td><td>Move</td><td>Close</td></tr><tr><td>Dow Jones Industrial Average</td><td>-0.26%</td><td>52,498.64</td></tr><tr><td>S&amp;P 500</td><td>-0.79%</td><td>7,515.34</td></tr><tr><td>Nasdaq Composite</td><td>-1.55%</td><td>25,873.18</td></tr></tbody></table></figure></div><h2 class="st-heading-2">US Market Drivers</h2>U.S. markets slid lower at the start of the week as rising tensions between the U.S. and Iran stoked worries of a war reboot and stirred inflation concerns.&nbsp;President Donald Trump announced on Monday that the U.S. would&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-reinstates-iranian-blockade-us-toll-20-cargo-strait-of-hormuz/cZmzHuwR7Yg">reinstate</a> a blockade on Iranian shipping through the critical Strait of Hormuz as the two countries exchanged fire once again.&nbsp;“We are reinstating the THE IRANIAN BLOCKADE, so named because it is only stopping Iran’s ships or customers from entering or leaving. All other countries will have fair and open use of the Strait,” he said in a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://truthsocial.com/@realDonaldTrump/posts/116913091653271692">post</a> on Truth Social.&nbsp;“The U.S.A. will be, from this point forward, known as ‘THE GUARDIAN OF THE HORMUZ STRAIT,’ but as such, and as a matter of FAIRNESS, will be reimbursed, at the rate of 20% on all cargo shipped, for any and all costs necessary to do the job of providing safety and security to this very volatile section of the World. The process and formation will begin immediately,” he added.&nbsp;However, the Persian Gulf Strait Authority, an Iranian agency created in May 2026 to oversee and regulate commercial shipping in the Strait, said in a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/PGSA_IRAN/status/2076634804745900264">post</a> on X, “Due to recent hostile actions by the US forces, passage through the #Strait_of_Hormuz is currently unfeasible. As soon as stability and calm are restored, all applications will be reviewed in accordance with the scheduled timeline, and the permitting process will resume.”Following the announcement, oil prices rallied, with Brent crude prices soaring more than 9% during trading hours, clocking their biggest single-day gain since 2020. Oil is now trading above $80 per barrel.&nbsp;Meanwhile, the U.S. Central Command also announced that it had launched further attacks against Iran. In a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/CENTCOM/status/2076775758299570613">post</a> on X, it said, “At 4:45 p.m. ET today, U.S. Central Command began launching the third consecutive night of strikes against Iran, at the Commander in Chief's direction. These strikes will continue imposing a heavy cost on Iranian forces and degrade their ability to attack innocent civilians and commercial shipping in the Strait of Hormuz.”The latest escalations come after a week of reciprocal strikes between the two nations. Tehran had earlier said that it had closed the Strait of Hormuz after the U.S.’s “hostile” attacks. Iran also went on to launch strikes on U.S. military facilities across several Gulf states in retaliation for military action from the U.S.&nbsp;A&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.politico.com/news/2026/07/13/trump-notifies-congress-of-new-war-against-iran-00995170">report</a> from POLITICO stated that Trump had formally notified Congress that the U.S. was once more at war with Iran, in a letter dated July 10.&nbsp;Meanwhile, markets will be bracing for the start of earnings season, with major banks kicking off their quarterly reports. JPMorgan Chase &amp; Co. (JPM), Bank of America Corp. (BAC), Citigroup Inc. (C), Wells Fargo &amp; Co. (WFC), and Goldman Sachs Group Inc. (GS) will be reporting their second-quarter results on Tuesday. “Today was a little bit of an outlier. Everything was kind of down today. But in general, it doesn’t really change the way we look at the earnings season. We feel pretty constructive about large tech in general. We do think earnings have some upside,” Michael Graham, director of research and investment strategy at Canaccord Genuity, reportedly&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.cnbc.com/closing-bell-overtime/">told</a> CNBC.&nbsp;On the economic front, investors will be watching June inflation data due Tuesday for clues on the Federal Reserve's next policy move. Meanwhile, Fed Chair Kevin Warsh is set to begin the semiannual monetary policy testimony before Congress on Tuesday, marking his first Humphrey-Hawkins appearance as head of the central bank.<h2 class="st-heading-2">Trending Stocks To Watch&nbsp;</h2>Oracle Corp. (ORCL):&nbsp;Shares of the hyperscaler jumped onto the retail radar after the company slipped to 52-week lows amid concerns about high debt levels and concentrated customer risk.&nbsp;SoundHound AI Inc. (SOUN):&nbsp;The voice and agentic AI company’s shares slid more than 2% on Monday, extending a third day of declines as short interest in the company climbed to a record high.&nbsp;Q32 Bio Inc. (QTTB):&nbsp;Shares of the biotechnology company&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/qttb-stock-clocks-best-day-in-a-year-following-positive-alopecia-data-analyst-sees-further-200-upside/cZmCTpsR7Yq">surged</a> more than 90% after the company’s 36-week results from the second part of its early-stage trial of bempikibart in patients with severe or very severe alopecia areata came in strong.&nbsp;Factorial Energy Inc. (FAC):&nbsp;The solid-state battery technology company’s stock plummeted more than 35% on Monday despite announcing a partnership with Tulip Tech, a Netherlands-based developer of advanced unmanned aerial vehicles battery systems.&nbsp;<h2 class="st-heading-2">Global Market Trends&nbsp;</h2>Crude oil prices shot up late Monday amid the growing conflict in the Middle East. At the time of writing, Brent crude futures expiring in September were up more than 1%, trading at $84.19 per barrel, while WTI crude futures expiring in August rose 1.6% to $79.39 per barrel.Yields on the 10-year Treasury rose to 4.62% at the time of writing, nearing a one-year high, while spot gold prices fell to around $3,997.47 per ounce.&nbsp;Asian markets were trading mixed on Tuesday, with South Korea's KOSPI and Japan’s Nikkei 225 declining at the open, while China’s SSE Composite index and Australian stocks were trading lower.&nbsp;&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

President Donald Trump mimics a Iranian protester being shot, while he conducts a news conference about the war in Iran in the White House briefing room on Monday, April 6, 2026. (Tom Williams/CQ-Roll Call, Inc via Getty Images)

Dow, S&P 500 Futures Slip While Nasdaq Holds Firm As Trump Reinstates Hormuz Blockade: ORCL, SOUN, QTTB, FAC In Focus

“The U.S.A. will be, from this point forward, known as ‘THE GUARDIAN OF THE HORMUZ STRAIT,’” Trump said on social media.

<ul class="summary-bullets"><li>The brokerage raised Q2 EBIT to $1.45 billion but still expects a $7.5 billion free cash flow outflow.</li><li>Jefferies said that a Tesla-SpaceX merger could leave room for a shareholder premium, with Musk retaining 55.3% voting control.</li><li>Tesla’s Semi will enter a pilot in Chicago with Paper Transport to test its 500-mile range in colder conditions.</li></ul>Shares of Tesla, Inc. (TSLA) rose 0.2% in overnight trading late Monday as Jefferies raised its price target and said that a potential SpaceX merger could leave room for a shareholder premium.<a href="https://stocktwits.com/symbol/TSLA">TSLA stock</a> fell 3% on Monday, snapping two straight sessions of gains.&nbsp;<h2 class="st-heading-2">Jefferies Lifts TSLA Outlook Ahead Of Q2 Earnings&nbsp;</h2>Jefferies raised its Tesla price target to $400 from $375 while maintaining a ‘Hold’ rating, implying a modest 1% upside from current levels. The firm cited Tesla’s “significant auto volume beat” after the company delivered 480,100 vehicles in the second quarter, well above the consensus estimate of 406,000. Model 3 and Model Y vehicles accounted for 467,800 deliveries. The brokerage said that the strength in China and Europe validated the “unique value proposition of Tesla vehicles,” even as the broader auto industry faces a growing risk of commoditization.The brokerage also said that Tesla’s multi-year deterioration in growth and earnings had started to reverse. Jefferies raised its second-quarter (Q2) earnings before interest and taxes (EBIT) forecast to $1.45 billion, representing a 5.1% margin, and increased its longer-term EBIT estimates by about 6%. Tesla is set to report its Q2 earnings on July 22.&nbsp;The firm now expects automotive revenue of $21 billion, including $250 million from zero-emission vehicle credits and $500 million from leasing. Group revenue and EBIT are projected at $28.7 billion and $1.45 billion, respectively. For fiscal 2026, Jefferies raised its EBIT estimate by 4% to $6.2 billion, partly reflecting stronger volumes and the higher-priced long-wheelbase Model Y.Jefferies also expects Q2 capital spending of $6.9 billion, leaving Tesla with $41.7 billion in liquidity. Deliveries running ahead of production should also provide a near-term cash-flow benefit by reducing inventory.However, Jefferies maintained its forecast of about $7.5 billion in free cash flow outflows, including $23 billion in capital expenditures. It also struck a cautious note on autonomy, saying low implied Cybercab production pointed to further delays in Tesla’s robotaxi ramp.<h2 class="st-heading-2">Tesla-SpaceX Merger Thesis Gains Steam</h2>The debate over a potential Tesla–SpaceX merger has evolved beyond retail speculation. What began as prominent retail&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tesla-shareholders-oppose-spacex-merger-robotaxi-optimus/cZKfPVSR7dB">investors</a>&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tesla-spacex-merger-bull-case-adds-450b/cZ0iVviRevM">modeling</a> ownership structures and exchange ratios has now drawn institutional attention, with firms such as Jefferies and JPMorgan publishing analytical frameworks that examine voting control, governance implications, and potential merger-premium structures.Jefferies said it continues to see logic in merging Tesla with Elon Musk’s privately held space company. Under a nil-premium deal, Musk would retain an estimated 55.3% voting stake in the combined entity. The structure, Jefferies said, could leave room for Tesla shareholders to receive a premium.The argument adds to growing Wall Street interest in whether Musk could eventually bring his automotive, AI, energy and space businesses closer together. JPMorgan recently called a Tesla-SpaceX merger “strategically coherent on paper,” pointing to potential integration across AI, robotics, energy, transportation and space. It maintained a ‘Neutral’ rating.<h2 class="st-heading-2">Tesla Semi Enters Chicago Pilot</h2>Separately, Tesla’s Semi is entering a new pilot program with Wisconsin-based Paper Transport. Paper Transport will test the long-range truck in dedicated Chicago operations, giving Tesla another opportunity to assess its performance in colder temperatures and snow-heavy conditions. The configuration offers about 500 miles of range and is priced at $290,000. Tesla has previously conducted Semi fleet trials with PepsiCo and Frito-Lay.<h2 class="st-heading-2">How Do Retail Traders Feel About TSLA?</h2>On Stocktwits, retail sentiment for TSLA was ‘bullish’ amid a 396% jump in 24-hour message volumes.<figure class="image"><img src="https://news.stocktwits-cdn.com/tsla_ss_png_46a33ce408.webp" alt="tsla ss.png" width="973" height="124"><figcaption>TSLA sentiment and message volume as of July 13| Source: Stocktwits</figcaption></figure>One user&nbsp;<a href="https://stocktwits.com/KingTrades09/message/658955550">said</a>, “$TSLA 390 has been holding for last couple days. earnings coming up. give me 450.”<stembedurl>https://stocktwits.com/KingTrades09/message/658955550</stembedurl>Another user&nbsp;<a href="https://stocktwits.com/EddieHayes/message/658950343">said</a>, “I actually feel better that Tesla isn't going parabolic heading into next week's earnings. Trading below $400 keeps the stock in a healthier range, and a strong earnings call or Elon Musk's commentary could spark a short squeeze.”<stembedurl>https://stocktwits.com/EddieHayes/message/658950343</stembedurl>So far this year, Tesla's stock has lagged its "Magnificent Seven" peers, making it the group's second-worst performer, down 12%.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/lnc-stock-pops-on-report-of-lincoln-nationals-potential-5-billion-reinsurance-deal-with-talcott/cZmCEI1R7Yu">LNC Stock Pops On Report Of Lincoln National’s Potential $5B Reinsurance Deal With Talcott&nbsp;</a>

In this photo illustration, the stock market information of Tesla Inc displayed on a smartphone while the logo of Tesla Inc seen in the background. (Photo Illustration by Igor Golovniov/SOPA Images/LightRocket via Getty Images)

TSLA Stock Back To $400? Jefferies Lays Out Bull Case, Says ​​SpaceX Merger Could Hand Shareholders A Premium

Jefferies said Tesla’s growth and earnings deterioration are beginning to reverse ahead of its July 22 results.

Oracle, Twin Vee PowerCats, Agenus, Micron Technology and SanDisk: Why These 5 Stocks Are on Investors' Radars Today

ORCL, VEEE, AGEN, MU, SNDK were among the stocks seen trending on Monday, July 13, 2026.read more...

<ul class="summary-bullets"><li>The S&amp;P 500 ended 0.8% lower, while the Nasdaq 100 fell 1.9% and the Dow Jones Industrial Average eased 0.3%.</li><li>Brent crude prices jumped over $80 per barrel.&nbsp;</li><li>Meta Platforms plans to spend $40 billion on its data center campus in Louisiana.</li></ul>U.S. stock indices ended lower on Monday as oil prices and bond yields spiked, following fresh U.S.-Iran tensions over the Strait of Hormuz, fanning inflation worries.&nbsp;The S&amp;P 500 ended 0.8% lower, while the Nasdaq 100 fell 1.9% and the Dow Jones Industrial Average eased 0.3%. The Russell 2000, which tracks stocks with small market capitalizations, fell 0.8%.Among ETFs tracking benchmark indexes, the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF (SPY)</a> dropped 0.8% and&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust&nbsp;</a>(QQQ) ended Monday around 2% lower, while the&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust</a> (DIA) fell 0.4%.&nbsp;Meanwhile, the VanEck Semiconductor ETF (<a href="https://stocktwits.com/symbol/SMH">SMH</a>) lost 4%, while the broader Vanguard Information Technology ETF (VGT) slipped about 2.2%, pushed lower by weakness in Nvidia (NVDA), SpaceX (SPCX), Broadcom (AVGO), Micron Tech (MU), Meta (META) and Tesla (TSLA).&nbsp;Retail sentiment on Stocktwits for SPY, QQQ and DIA was between ‘bullish’ and ‘neutral’ zones with ‘normal’ to ‘high’ message volumes.<h2 class="st-heading-2">US Market Drivers</h2>&nbsp;<div><figure class="table"><table class="ck-table-resized"><colgroup><col><col><col></colgroup><tbody><tr><td>Index</td><td>Move</td><td>Close</td></tr><tr><td>Dow Jones Industrial Average</td><td>-0.3%</td><td>52,498.64</td></tr><tr><td>S&amp;P 500</td><td>-0.8%</td><td>7,515.34&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td></tr><tr><td>Nasdaq 100</td><td>-1.9%</td><td>29,264.10&nbsp;&nbsp;&nbsp;</td></tr></tbody></table></figure></div>Memory chip stocks led Monday's declines, with SanDisk (SNDK) and Western Digital led declines most as investors grew concerned about the high-bandwidth memory (HBM) supply chain.The primary driver for Monday’s weakness was a surge in oil price above the $80 per barrel level that stoked inflation worries, raising bets for a sooner-than-expected interest rate hike.&nbsp;“We are reinstating the THE IRANIAN BLOCKADE, so named because it is only stopping Iran’s ships or customers from entering or leaving,” Trump said in a post on Truth Social.“The U.S.A. will be, from this point forward, known as ‘THE GUARDIAN OF THE HORMUZ STRAIT,’ but as such, and as a matter of FAIRNESS, will be reimbursed, at the rate of 20% on all cargo shipped, for any and all costs necessary to do the job of providing safety and security to this very volatile section of the World,” he continued.The most recent escalation followed a weekend of mutual airstrikes between the U.S. and Iran. Tehran claimed it had shut down the Strait of Hormuz after targeting U.S. facilities in multiple Gulf nations.&nbsp;“The energy sector is once again in the limelight as the status of the Strait of Hormuz is driving price action in global markets,” said Ian Lyngen at BMO Capital Markets. “There is a growing sense that the situation is likely to get worse before it de-escalates.”&nbsp;<h2 class="st-heading-2">Trending Stocks To Watch&nbsp;</h2>Paramount Skydance Corporation (PSKY): The company on Monday pushed back against a newly filed multi-state lawsuit aiming to block its historic $110-billion acquisition of Warner Bros. Discovery Inc. (WBD), warning that delaying the transaction will only harm entertainment workers and benefit dominant Silicon Valley tech platforms.&nbsp;Alphabet (GOOG, GOOGL): Google is reportedly expanding efforts to sell its custom AI chips to independent cloud providers as a direct challenge to Nvidia's (NVDA) dominance in AI hardware.&nbsp;Intel (INTC): The U.S. chipmaker plans to invest $5.7 billion to expand manufacturing capabilities at its Leixlip campus in Ireland, as part of its latest push to address the chip shortage driven by demand for AI infrastructure.&nbsp;Netflix (NFLX): Oppenheimer lowered its price target on Netflix to $100 from $120, while KeyBanc analyst Justin Patterson reduced his target to $92 from $115 ahead of results due this week.&nbsp;Apple (AAPL): The Cupertino, California-based tech giant saw its shipments grow 3% year-over-year in Q2, securing a historic 20% share of the second-quarter global market for the first time, according to Centerpoint.&nbsp;&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

The New York Stock Exchange stands on Wall Street in New York City

S&P 500, Nasdaq, Dow End Lower As US-Iran War Fear Remerges — PSKY, META, GOOGL, INTC, NFLX In Focus

U.S. stock indices ended lower on Monday as oil prices and bond yields spiked, following fresh U.S.-Iran tensions over the Strait of Hormuz, fanning inflation worries.&nbsp;

S&P 500, Nasdaq, Dow End Lower As US-Iran War Fear Remerges — META, SKHVY, CRCL, BA, DAL In Focus

President Donald Trump said the U.S. would resume a blockade of Iranian ships transiting the Strait of Hormuz.

<ul class="summary-bullets"><li>Keytruda generated $31.7 billion in 2025, accounting for 55% of Merck’s pharma revenue ahead of its 2028 U.S. patent cliff.</li><li>The SLS thesis centers on GPS, an AML immunotherapy nearing its pivotal Phase 3 final analysis after reaching 78 of 80 required events.</li><li>MLTX has prior Merck interest and is preparing an FDA filing for its lead drug, Sonelokimab, to treat a chronic inflammatory skin disease.</li></ul>Sellas Life Sciences (SLS) and MoonLake Immunotherapeutics (MLTX) have emerged as retail’s leading candidates for Merck &amp; Co.’s (MRK) next biotech deal as the drugmaker prepares for life beyond Keytruda.<a href="https://stocktwits.com/symbol/SLS">SLS</a> and&nbsp;<a href="https://stocktwits.com/symbol/MLTX">MLTX</a> each gained more than 2% at the start of overnight trading late Sunday, while&nbsp;<a href="https://stocktwits.com/symbol/MRK">MRK</a> edged marginally higher.<h2 class="st-heading-2">MRK’s Keytruda Raises Stakes For New Deals</h2>Merck said on Friday that the U.S. Food and Drug Administration (FDA) approved Keytruda, its flagship cancer drug, and Keytruda Qlex, a newer version given as an injection under the skin, each in combination with Pfizer and Astellas’ Padcev, for use before and after surgery in adults with muscle-invasive bladder cancer. The approval expands Keytruda’s already dominant cancer franchise, while also underscoring Merck’s dependence on it.Keytruda and Keytruda Qlex generated $31.7 billion in 2025, equal to about 55% of Merck’s $58.1 billion in pharmaceutical revenue. Since 2020, Keytruda sales have more than doubled, while the total pharmaceutical business has grown at a much slower pace. Keytruda now generates more than half of Merck’s pharmaceutical revenue.<img src="https://news.stocktwits-cdn.com/Keytruda_Now_Generates_Over_Half_Of_Mercks_Pharma_Revenue_jpg_83ba2bdee9.webp" alt="Keytruda_Now_Generates_Over_Half_Of_Mercks_Pharma_Revenue.jpg">The concentration has become more important as Keytruda nears the loss of its U.S. exclusivity, beginning in 2028. Merck reorganized its human-health operation in February, creating a dedicated oncology division as it seeks to preserve its leadership beyond Keytruda. It has also spent heavily on acquisitions, including Verona Pharma, Cidara Therapeutics, and Terns Pharmaceuticals.After outlining Merck’s post-Keytruda growth plans earlier this year, CEO Robert Davis told investors: “And we’re not done.” Retail traders are taking him at his word.<h2 class="st-heading-2">Why SLS Bulls See A Merck Buyout</h2>The Sellas thesis centers on galinpepimut-S (GPS), the company’s WT1-targeting immunotherapy. Sellas is evaluating GPS in the Phase 3 Regal trial as a maintenance therapy for acute myeloid leukemia (AML) patients who entered remission following second-line treatment. The study has recorded 78 of the 80 patient-death events required to trigger its final analysis, placing the program near a potentially final readout.Sellas has said the trial would be successful if GPS achieves a median overall survival of at least 12.6 months, compared with 8 months in the control arm. The trial remains blinded, meaning the slower accumulation of events may be encouraging but does not prove that GPS succeeded. On the other hand, retail interest is heating up: Stocktwits sentiment eased to ‘bullish’ from ‘extremely bullish’ a week earlier, even as 24-hour message volume surged 53% and the stock’s watcher count climbed 5% over the past month.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/sls_ss_png_602e80c1ea.webp" alt="sls ss.png" width="968" height="130"><figcaption>SLS sentiment and message volume as of July 12| Source: Stocktwits</figcaption></figure>“Things are heating up for SLS,” one bullish user&nbsp;<a href="https://stocktwits.com/ICEMAN_ALERT/message/658858554">said</a>, while another trader&nbsp;<a href="https://stocktwits.com/HeyBenTaco/message/658850187">argued</a>: “Over $30 billion of revenue [is] in jeopardy. Who will they buy to extend keytrudas patent monopoly?” The user called Sellas as one possible answer and suggested that competing interest from other pharma companies could force Merck to act.&nbsp;Other SLS bulls believe GPS could ultimately have uses beyond AML because WT1 is expressed across numerous cancers. “GPS is the one therapy that has such a wide multi-platform application potential,” one user&nbsp;<a href="https://stocktwits.com/10xorbust/message/658847033">said</a>, arguing that only a large pharma company such as Merck could finance the trials required to test the therapy broadly.Another trader&nbsp;<a href="https://stocktwits.com/dewmoore/message/658852176">warned</a> that Merck could weaken its cancer position if a competitor moved first: “If SLS falls into the hands of LLY, JNJ or PFE, Merck loses their oncology crown.”&nbsp;Merck’s $6.7 billion acquisition of Terns in March strengthened the retail thesis. The deal gave Merck TERN-701, an investigational drug for chronic myeloid leukemia still in Phase 1/2 testing. “They need to take bigger risks at this moment in the industry,” one SLS bull&nbsp;<a href="https://stocktwits.com/Coloradical/message/658850441">said</a>. “I think SLS is the right play to combine with Keytruda.” Traders have also highlighted CEO Angelos Stergiou’s Fourth of July reference to “strategic partners” and amended executive agreements containing change-of-control provisions.&nbsp;<h2 class="st-heading-2">Merck’s Past Bid Fuels MLTX Buzz&nbsp;</h2>MoonLake investors have one advantage Sellas bulls do not: a previously reported approach from Merck. Merck&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.ft.com/content/5899ea69-e5fe-49f1-8ada-79f26c9254d8?syn-25a6b1a6=1">reportedly</a> submitted a nonbinding offer valuing MoonLake at more than $3 billion last year. The initial approach was rejected, although talks could potentially be revived. The Merck connection is once again driving attention toward MLTX. Stocktwits sentiment for MLTX improved to ‘bullish’ from ‘neutral’ a day earlier, while weekly message volume surged 760% and the stock’s watcher count rose 5% over the past month.<figure class="image"><img src="https://news.stocktwits-cdn.com/mltx_ss_png_1931b9a853.webp" alt="mltx ss.png" width="975" height="128"><figcaption>MLTX sentiment and message volume as of July 12| Source: Stocktwits</figcaption></figure>“Don’t think SLS is the target if Friday’s action says anything,” one trader&nbsp;<a href="https://stocktwits.com/InsuranceSalesman/message/658849317">said</a>, arguing that MoonLake held up better on strong volume while SLS moved with the broader biotech sector. “Tells me something is up with MLTX, not SLS,” the user added.MoonLake’s lead drug, Sonelokimab, has completed Phase 3 development in hidradenitis suppurativa. At one year, 67% of patients achieved a strong improvement in disease severity, 33% reached complete skin clearance under a key measure and 26% achieved inflammatory remission. The company plans to submit a Biologics License Application (BLA) to the FDA by Sept.30 and request Priority Review.“When will rumors turn into reality?” one MLTX bull&nbsp;<a href="https://stocktwits.com/timetravelBob/message/658845941">said</a>. “MRK needs to buy something! Let it [be] MLTX.” Another user&nbsp;<a href="https://stocktwits.com/StockQB/message/658851019">claimed</a> MoonLake was “in talks with MRK for a buyout,” although neither company has confirmed any negotiations.<h2 class="st-heading-2">SLS Outruns MLTX As Buyout Pressure Builds</h2>Since Merck announced its acquisition of Terns, SLS shares have risen 155%, compared with 22% for MLTX and 6% for Merck.&nbsp;<img src="https://news.stocktwits-cdn.com/SLS_Leaves_MLTX_And_MRK_Behind_With_155_Rally_Since_Terns_Deal_jpg_7bd652b923.webp" alt="SLS_Leaves_MLTX_And_MRK_Behind_With_155_Rally_Since_Terns_Deal.jpg">Meanwhile, Sellas carries a market cap of about $2.4 billion and an enterprise value of $2.3 billion. MoonLake is valued at $1.5 billion, with an enterprise value of about $1.2 billion. MoonLake also held $298.5 million in cash at the end of the first quarter, compared with $107.2 million for Sellas.<img src="https://news.stocktwits-cdn.com/SLS_Carries_Nearly_Twice_MLT_Xs_Enterprise_Value_But_Less_Cash_jpg_ab90f167b3.webp" alt="SLS_Carries_Nearly_Twice_MLTXs_Enterprise_Value__But_Less_Cash.jpg">David Giroux, chief investment officer at T. Rowe Price Investment Management,&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.barrons.com/articles/barrons-roundtable-stock-picks-top-investors-ab1990a9">told</a> Barron’s on Friday that large pharma companies face a $400 billion to $500 billion patent-expiration hole over the next decade that internal research alone cannot fill. He expects a “tremendous number” of small and mid-cap biotech firm to be acquired at premiums of 50% to 100%. Giroux specifically named MoonLake among seven potential targets. “I would be shocked if all weren’t acquired in the next few years for big premiums over their current value,” he said.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/default/5/nasdaq-sp500-dow-futures-fall-after-trump-directs-strikes-to-hold-iranian-forces-accountable/cZmz7lkR7o7">Nasdaq, S&amp;P 500, Dow Futures Fall After Trump Directs Strikes ‘To Hold Iranian Forces Accountable’: NVDA, SLS, MRK, SKHYV, QS Stocks In Focus&nbsp;</a>

A syringe and some pills are in front of the logo of Merck pharmaceutical company. (Photo by Nikos Pekiaridis/NurPhoto via Getty Images)

SLS Vs MLTX: Retail Traders Race To Pick Merck’s Next Biotech Buyout As Keytruda’s $31.7B Patent Cliff Nears

SLS leads in stock momentum, while MLTX is cheaper and better-funded, with nearly $300 million in cash at the end of the first quarter.

<ul class="summary-bullets"><li>Judge Thomas Barber ruled the newspaper did not act with actual malice, citing reporter Drew Harwell's investigation.</li><li>The lawsuit stemmed from a 2023 Washington Post report on Truth Social's financing before its merger with Digital World Acquisition Corp.&nbsp;</li><li>The ruling adds to Trump Media's challenges as its stock remains down nearly 40% this year.&nbsp;</li></ul>Trump Media &amp; Technology Group Corp. (DJT) suffered a significant legal setback after a federal judge dismissed the company's $3.8 billion defamation lawsuit against The Washington Post.&nbsp;U.S. District Judge Thomas Barber&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.law360.com/dockets/download/6a4b9a57a247a52a9b7e03bc?doc_url=https%3A%2F%2Fecf.flmd.uscourts.gov%2Fdoc1%2F047130440622&amp;label=Case+Filing">ruled</a> in favor of The Washington Post, saying Trump Media did not provide enough evidence to show the newspaper acted with "actual malice," the legal requirement for public figures to win a defamation lawsuit.<h2 class="st-heading-2">Judge Cites Reporting Process, Rejects Actual Malice Claim&nbsp;</h2>The lawsuit emerged from a May 2023 Washington Post report about financing for Trump's Truth Social platform before its merger with Digital World Acquisition Corp. The story covered an $8 million loan and a proposed $240,000 referral fee that Trump Media said was reported incorrectly.&nbsp;Trump Media originally sought $3.8 billion in damages, saying the article damaged its reputation and business. As the case moved forward, it was narrowed to two statements about whether the referral fee had actually been paid.Judge Barber ruled that the evidence did not support a finding that The Washington Post knowingly published false information or acted with disregard for the truth.&nbsp;The decision cited the reporting process undertaken by journalist Drew Harwell, who interviewed former Trump Media co-founder Will Wilkerson and reviewed documents available during the investigation.Although The Washington Post later issued a correction acknowledging that discovery showed the referral fee had not been paid, the court found that the correction did not establish actual malice at the time of publication.<a href="https://stocktwits.com/symbol/DJT">Trump Media &amp; Technology stock</a> edged 0.5% higher overnight, ahead of Wednesday.&nbsp;<h2 class="st-heading-2">DJT Stock Remains Under Pressure As Financial Challenges Persist&nbsp;</h2>The ruling comes as the social media company's shares continue to struggle in 2026, adding another challenge for a business already facing weak financial performance and investor concerns.The stock has fallen nearly 40% so far this year after dropping to a record low in late June as investors focus on the company's underlying financial performance rather than momentum-driven trading.The company's Truth Social platform generated less than $1 million in revenue during the first quarter while net losses widened to $406 million. Ongoing spending on technology infrastructure, legal matters and operations has kept expenses elevated, reinforcing concerns about the pace at which the business can achieve sustainable growth.Trump Media also surprised investors with plans announced in late 2025 to merge with fusion energy developer TAE Technologies in an all-stock transaction valued at more than $6 billion. The proposed deal would expand the company's focus beyond social media, prompting questions about its long-term corporate strategy and business identity.<h2 class="st-heading-2">DJT Retail View&nbsp;</h2>On Stocktwits, retail sentiment around the stock remained in ‘extremely bullish’ territory. The stock saw a 29% increase in message volume over the past week, with watchers remaining flat.&nbsp;DJT stock has crashed 57% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/crml-uuuu-usar-aloy-glnd-greenland-rare-earth-trade-draws-investors-as-trump-revives-arctic-ambitions/cZmVhjrR7NG">CRML, UUUU, USAR, ALOY, GLND: Greenland’s Rare-Earth Trade Draws Investors As Trump Revives Arctic Ambitions</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A person holds a smartphone displaying the Truth Social app page on the Apple App Store, with the Trump Media & Technology Group logo visible in the background, on November 6, 2024, in Chongqing, China.

DJT Stock In Focus: Federal Judge Throws Out Trump Media Defamation Lawsuit Against The Washington Post 

Trump Media &amp; Technology Group Corp. (DJT) suffered a significant legal setback after a federal judge dismissed the company's $3.8 billion defamation lawsuit against The Washington Post.&nbsp;

The decision adds another challenge for DJT as investors grapple with weak financial results and questions over the company's evolving strategy.

SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is experiencing extreme volatility and intense community discussion following a massive sell-off, driven by fears of margin call liquidations and significant rebalancing within the South Korean market. Investors are keenly watching the upcoming 20-for-1 forward stock split and the debut of SK Hynix on the Nasdaq as major catalysts for potential price stabilization and renewed market interest.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is experiencing significant volatility as investors weigh its massive AI infrastructure investments and debt levels against strong cloud backlog growth. The community remains deeply divided, with many traders debating whether the stock is an oversold long-term value opportunity or a sinking asset facing further technical breakdowns.

Q32 Bio, Inc. operates as a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. It focuses on the IL-7 / TSLP receptor pathways and complement system, addressing immune dysregulation to help patients take back control of their lives. The company was founded by David Grayzel and Shelia Violette in 2017 and is headquartered in Waltham, MA.

Q32 Bio Inc.

Q32 Bio is currently trending as investors react to the company's latest clinical trial results, while community discussion remains heavily focused on the implications of a recent massive capital raise. Traders are actively debating the stock's future direction, weighing the potential for a short squeeze against concerns regarding future dilution.

Conagra Brands, Inc. engages in the manufacture and sale of processed and packaged foods. It operates through the following segments: Grocery and Snacks, Refrigerated and Frozen, International, and Foodservice. The Grocery and Snacks segment includes branded, and shelf stable food products sold in various retail channels in the United States. The Refrigerated and Frozen segment is composed of branded, and temperature-controlled food products sold in various retail channels in the United States. The International segment offers branded food products in various temperature states, sold in various retail and foodservice channels outside of the United States. The Foodservice segment focuses on branded and customized food products, including meals, entrees, sauces, and a variety of custom-manufactured culinary products packaged for sale to restaurants and other foodservice establishments in the United States. The company was founded by Alva Kinney and Frank Little in 1919 and is headquartered in Chicago, IL.

Conagra Brands Inc

Conagra Brands is experiencing heightened volatility and significant selling pressure following the announcement of a new CEO, which has community members debating the safety of its high dividend yield and the potential for a strategic restructuring. Investors are actively analyzing the stock's valuation as it touches multi-decade lows, with a mix of bargain hunters accumulating shares based on insider buying signals and cautious traders fearing further downside or an eventual dividend cut.

BNB is the native utility token of the BNB Chain ecosystem, acting as a multi-chain asset that powers decentralized applications and facilitates value exchange across its network. It serves as the primary asset for paying transaction gas and smart contract deployment fees while providing users with tiered fee discounts on the Binance exchange. The project’s main value proposition lies in its unified multi-chain architecture, which integrates a smart contract platform, a Layer 2 scaling solution, and a decentralized data storage network into a cohesive settlement and data availability layer.  The network operates on a Proof of Staked Authority consensus mechanism, utilizing a group of 21 active validators known as the Cabinet to verify transactions and produce blocks every 3 seconds. Validators are elected daily based on the amount of BNB staked or delegated to them, and the system employs fast finality and slashing penalties to maintain security and integrity. To manage its long-term economy, the project uses a programmatic dual-burn strategy that permanently removes tokens through real-time fee destruction and quarterly buybacks.  Launched in 2017 by the Binance platform, the project initially distributed 50% of its 200 million token supply to the public, while the founding team received 40% and angel investors were allocated 10%. Though it began as a token on the Ethereum network, it eventually migrated to its own autonomous architecture that remains fully compatible with the Ethereum Virtual Machine. Today, the token's utility includes paying for network gas, participating in staking rewards, and enabling decentralized governance through which holders can vote on technical upgrades and economic changes.

Binance

Binance is experiencing increased market activity as traders monitor potential downside risks linked to technical patterns and macro-economic factors. Community sentiment remains mixed, with discussions centering on the Binance Chain's role in the evolving AI trading narrative alongside ongoing concerns regarding regulatory scrutiny and broader market volatility.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

Cleanspark is seeing heightened community discussion as traders monitor its strategic pivot toward AI and high-performance computing, with many waiting for a major infrastructure or hyperscaler partnership to materialize. While the stock continues to face volatility and significant short interest, bullish sentiment remains anchored in its expanding power capacity and potential for a long-term re-rating in the energy-intensive AI sector.

ETF Opportunities Trust - Roundhill T-REX 2X Long DRAM Daily Target ETF

T-REX 2X Long DRAM Daily Target ETF

The RAM leveraged ETF is seeing intense community focus due to its role as a 2x long proxy for the memory sector during a volatile period for DRAM and semiconductor stocks. Investors are actively debating the sustainability of the AI memory supercycle and the risks of holding highly leveraged products amidst sharp daily fluctuations and broader market uncertainty.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is trending as traders speculate on potential buyout rumors and aggressive stock buybacks, while technical traders closely watch key resistance levels for a long-awaited breakout. Community sentiment remains highly polarized, ranging from frustration over the stock's sluggish performance to optimism regarding its deep value and long-term turnaround potential.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros. Discovery is seeing heightened market attention as shareholders prepare for an April 23 vote on the $110 billion merger with Paramount Skydance, an event overshadowed by intense industry backlash and scrutiny over executive compensation. The community is actively debating the merger's potential to create a streaming powerhouse capable of challenging major tech platforms, despite ongoing antitrust concerns and legal challenges from state attorneys general.

Vanguard Index Funds - Vanguard S&P 500 ETF

Vanguard S&P 500 ETF

Investors are actively debating the potential for continued market growth against a backdrop of geopolitical tension and shifting monetary policy expectations. While some maintain a focus on long-term wealth compounding through consistent participation in broad indices like VOO, others are closely monitoring high-stakes catalysts including corporate earnings, diplomatic developments in the Middle East, and potential shifts in Federal Reserve strategy.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


News